EDWIN CZOVEK: Open Payments
NPI 1891867396 · ZEPHYRHILLS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 20 payments from 7 companies in 2025. Trend: 2023 $684 · 2024 $901 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 6 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $122 |
| Axsome Therapeutics, Inc. | 4 | $71 |
| ABBVIE INC. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $32 |
| Noven Therapeutics, LLC | 1 | $25 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $23 |
Products named: Azstarys, TRINTELLIX, Auvelity, VRAYLAR, CAPLYTA, Xelstrym, Quviviq.
Industry payments across FL — which companies pay providers there.
